APL Healthcare Ltd's Unit-4 gets 5 observations from USFDA

The United States Food and Drug Administration (US FDA) inspected Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the Company, situated at Palchur village and part of Palepalem Village Naidupeta Mandal, SPSR Nellore District, 524126, Andhra Pradesh, from December 08 to December 17, 2025.

At the end of the current inspection, a 'Form 483' was issued with 05 observations which are procedural in nature, and we will respond to the US FDA within the stipulated timelines.

The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1193.05 as compared to the previous close of Rs. 1178.20. The total number of shares traded during the day was 13089 in over 1106 trades.

The stock hit an intraday high of Rs. 1196.50 and intraday low of 1174.00. The net turnover during the day was Rs. 15560006.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals APLHealthcare Unit4 USFDA Form483 5Observations